These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16925734)
1. Serum prostate-specific antigen levels in older men with or at risk of HIV infection. Vianna LE; Lo Y; Klein RS HIV Med; 2006 Oct; 7(7):471-6. PubMed ID: 16925734 [TBL] [Abstract][Full Text] [Related]
2. Prostate carcinoma among men with human immunodeficiency virus infection. Crum NF; Spencer CR; Amling CL Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826 [TBL] [Abstract][Full Text] [Related]
3. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Klein RS; Lo Y; Santoro N; Dobs AS Clin Infect Dis; 2005 Dec; 41(12):1794-803. PubMed ID: 16288406 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of prostate specific antigen testing for prostate cancer in elderly men. Dyche DJ; Ness J; West M; Allareddy V; Konety BR J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807 [TBL] [Abstract][Full Text] [Related]
5. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054 [TBL] [Abstract][Full Text] [Related]
6. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis. Partin AW; Criley SR; Subong EN; Zincke H; Walsh PC; Oesterling JE J Urol; 1996 Apr; 155(4):1336-9. PubMed ID: 8632568 [TBL] [Abstract][Full Text] [Related]
7. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old. Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597 [TBL] [Abstract][Full Text] [Related]
8. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. Culp S; Porter M BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868 [TBL] [Abstract][Full Text] [Related]
9. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy? Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907 [TBL] [Abstract][Full Text] [Related]
10. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer. Lin KJ; Pang ST; Chang YH; Wu CT; Chuang KL; Chuang HC; Chuang CK Chang Gung Med J; 2010; 33(2):182-7. PubMed ID: 20438671 [TBL] [Abstract][Full Text] [Related]
11. Predictors of prostate cancer screening among health fair participants. Chiu BC; Anderson JR; Corbin D Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522 [TBL] [Abstract][Full Text] [Related]
12. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening. Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. D'Amico AV; Renshaw AA; Sussman B; Chen MH JAMA; 2005 Jul; 294(4):440-7. PubMed ID: 16046650 [TBL] [Abstract][Full Text] [Related]
15. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Xie W; Nakabayashi M; Regan MM; Oh WK Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608 [TBL] [Abstract][Full Text] [Related]
16. Serum folate and prostate-specific antigen in the United States. Han YY; Song JY; Talbott EO Cancer Causes Control; 2013 Aug; 24(8):1595-604. PubMed ID: 23702887 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511 [TBL] [Abstract][Full Text] [Related]
18. Elevated Serum PSA is Associated With Human Herpesvirus 8 Infection and Increased Circulating Cytokine Levels in Men From Tobago. Henning JD; Karamchandani JM; Bonachea LA; Bunker CH; Patrick AL; Jenkins FJ Prostate; 2017 May; 77(6):617-624. PubMed ID: 28117495 [TBL] [Abstract][Full Text] [Related]
19. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL. Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144 [TBL] [Abstract][Full Text] [Related]
20. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial. Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]